CIP
HAE icon

Convergence Investment Partners’s Haemonetics HAE Stock Holding History

Convergence Investment Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-22,200
Closed -$2.54M – 333
2018
Q3 		$2.54M Sell
22,200
-17,279
-44% -$1.79M 0.52% 60
2018
Q2 		$3.54M Buy
39,479
+21,587
+121% +$1.82M 0.49% 73
2018
Q1 		$1.31M Sell
17,892
-17,248
-49% -$1.18M 0.17% 201
2017
Q4 		$2.04M Sell
35,140
-190
-0.5% -$10K 0.27% 124
2017
Q3 		$1.58M Buy
35,330
+340
+1% +$14.1K 0.22% 174
2017
Q2 		$1.38M Buy
+34,990
New +$1.44M 0.2% 193

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return